Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | +0.51% | -1.00% | -3.86% |
Sales 2024 * | 9.05B 1.25B | Sales 2025 * | 9.96B 1.37B | Capitalization | 21.92B 3.02B |
---|---|---|---|---|---|
Net income 2024 * | 1.17B 162M | Net income 2025 * | 1.4B 193M | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.2 x |
P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
18.4
x | Employees | 4,619 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.08% |
1 day | +0.51% | ||
1 week | -1.00% | ||
Current month | -1.00% | ||
1 month | -1.49% | ||
3 months | +15.70% | ||
6 months | +11.80% | ||
Current year | -3.86% |
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.99 | +0.51% | 161 800 |
24-04-22 | 1.98 | -0.50% | 104,400 |
24-04-19 | 1.99 | 0.00% | 16,700 |
24-04-18 | 1.99 | 0.00% | 92,600 |
24-04-17 | 1.99 | -1.00% | 70,800 |
Delayed Quote Singapore S.E., April 23, 2024 at 05:04 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.54% | 6.12B | |
-16.47% | 4.44B | |
-10.16% | 3.14B | |
-1.06% | 2.57B | |
+40.09% | 1.87B | |
-0.76% | 1.63B | |
-11.19% | 1.62B | |
-12.74% | 1.53B | |
+40.43% | 1.45B |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock